Compliance in Pain Management: UDT Testing

For providers treating pain patients, the use of Urine Drug Testing (or UDT) is a mechanism used to ensure the safe and effective use of prescription medications, particularly opioids.

Such diagnostic testing monitors adherence to prescribed therapies, detects potential drug use or misuse and identifies the presence of illicit substances.

Unfortunately, healthcare providers across the country treating pain patients often find themselves the target of government scrutiny for performing this type of diagnostic testing.

Recently, a multi-location pain management practice has found themselves at the center of a government investigation centered around their clinical decision to perform UDTs on its patients.

From risking allegations of healthcare fraud, DEA regulation violations, and pharmacy exclusions, providers who treat pain can often find it extremely difficult to navigate regulations while focusing on providing patient care.

With Such Complex Guidance, How Can Healthcare Providers Ensure They are Protected From Similar Regulatory Scrutiny?

The key to mitigating risk is through a comprehensive compliance plan formulated by the experts at Chapman Consulting Group. Our team of knowledgeable experts have experience in healthcare regulations to ensure that your practice is protected with the policies and procedures you need to reduce potential risk of noncompliance.

If you are a healthcare provider in need of compliance guidance, contact the team at Chapman Consulting Group today for your no obligation consultation!